Product Information
DOCUSATE SODIUM 250 MG SOFTGEL is a generic product labeled by Major Pharmaceuticals, priced at $0.0523 per EA under NDC 00904728180. Its NADAC has been published 163 times since Aug 23, 2023.
The High Outlier badge above means this manufacturer's average price in the Docusate Sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904728180
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOCUSATE SODIUMApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
10/14/2022
Price Statistics
The NADAC for DOCUSATE SODIUM 250 MG SOFTGEL has been published 163 times since Aug 23, 2023, and over the history we have for it it has risen 25.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0523 per EA |
|---|---|
| All-time high | $0.0551 (Aug 12, 2026) |
| All-time low | $0.0365 (Jul 17, 2024) |
| 52-week high | $0.0551 |
| 52-week low | $0.0493 |
| Median price | $0.0506 |
| Average price | $0.0494 |
| Largest weekly change | +29.0% (Aug 21, 2024) |
| Weeks tracked | 163 |
| Tracking since | Aug 23, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Docusate Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOCUSATE SODIUM 250 MG SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for DOCUSATE SODIUM 250 MG SOFTGEL, manufactured by Major Pharmaceuticals, is $0.0523 per EA (NDC 00904728180), effective Sep 30, 2026.
How has the price of DOCUSATE SODIUM 250 MG SOFTGEL changed over time?
Over the history we have for it, the NADAC for DOCUSATE SODIUM 250 MG SOFTGEL has risen 25.6%. It has been tracked across 163 weekly CMS publications since Aug 23, 2023.
What are the highest and lowest recorded NADAC prices for DOCUSATE SODIUM 250 MG SOFTGEL?
Since Aug 23, 2023, the NADAC for DOCUSATE SODIUM 250 MG SOFTGEL has ranged from a low of $0.0365 (Jul 17, 2024) to a high of $0.0551 (Aug 12, 2026), with a median of $0.0506 per EA.
Are there cheaper alternatives to DOCUSATE SODIUM 250 MG SOFTGEL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOCUSATE SODIUM 250 MG SOFTGEL in a comparable dosage form, but none are currently priced below it.
Who manufactures DOCUSATE SODIUM 250 MG SOFTGEL?
DOCUSATE SODIUM 250 MG SOFTGEL (NDC 00904728180) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.